AI assistant
Blis Technologies Limited — Capital/Financing Update 2021
Jul 6, 2021
66168_rns_2021-07-07_e7c7773f-ce7a-4ae1-bcc1-145f891a8483.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [455 x 62] intentionally omitted <==
7 July 2021
Investor call regarding announcement of Probi investment in Blis
Blis Technologies Limited (NZX:BLT) has today announced the formation of a long term strategic partnership with Probi AB (PROB.STOE), a global company based in Sweden that is focused exclusively on developing, producing, and delivering clinically proven probiotics.
The key terms of the agreement are:
-
Issue of new shares to provide Probi with a 13% cornerstone shareholding (post issue).
-
Establishment of a licence and supply agreement that sees Blis grant Probi the right to manufacture and distribute BLIS K12™, BLIS M18™ and the opportunity to collaborate on future strains.
Blis CEO Brian Watson will host an investor call to discuss the announcement. The call is scheduled for:
Today, Wednesday 7 July 2021 at 10:30am NZST
To join the conference call either:
- Pre-register at https://s1.c-conf.com/diamondpass/10014883-wdmr7o.html
OR
- Dial in to one of the numbers below at least five minutes prior to the scheduled call time and advise the operator you are calling to join the Blis Technologies call. The conference code is 10014883 .
New Zealand 09 929 1687 Australia 1800 809 971 International +61 7 3145 4010
Ends
For further information, please contact:
Brian Watson CEO +64 27 705 9133
==> picture [455 x 68] intentionally omitted <==
About Blis Technologies Ltd
Delivering proven health benefits through evidence-based, advanced probiotics
Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz.
Website: www.unconditionalskin.com
Instagram: @unconditionalskin #BLISQ24 #USC Facebook: @unconditionalskin
Blis Technologies Limited: 81 Glasgow Street, South Dunedin 9012, PO Box 2208, Dunedin 9012, New Zealand T:+64 3 474 0988 E: [email protected] W: www.blis.co.nz